POSTER SESSION 2 / DRINKS — ASN Events
6:00PM - 7:00PM
Exhibition Hall
Sponsored by:

Numbered abstracts 135 – 205

#ids2013meeting

Diab-Q-Kit II: Next generation combinatorial nanotechnology for profiling islet autoreactive CD8 T-cells for immune memory and activation (#135)

6:00 PM
Joana Abreu

Haploinsufficiency of Interferon regulatory factor 4 strongly protects from autoimmune diabetes in the non-obese diabetic mice (#137)

6:00 PM
Satoru Akazawa

Serum miRNA profile in children with high risk for type 1 diabetes (#138)

6:00 PM
Linda Åkerman

Functional Modification of Epidermal Dendritic Cells by Topical Steroids to optimize Tolerogenic Potential of Immunotherapy for Type 1 Diabetes (#139)

6:00 PM
Mohammad Alhadj Ali

Investigation of  Slc16a10’s role in immune cell function and autoimmune diabetes (#140)

6:00 PM
May Alsayb

T-cell regulation by a trimolecular complex of CD52, HMGB1 and Siglec-10 (#141)

6:00 PM
Esther Bandala-Sanchez

MicroRNA profiling of impaired CD4+ T regulatory cells residing in the pancreatic draining lymph-nodes of patients with type 1 diabetes (#142)

6:00 PM
Manuela Battaglia

Anti-CD2 producing pig xenografts effect localized depletion of human T cells in a huSCID model (#145)

6:00 PM
Jamie L Brady

Allergy to self: the role of mast cell in the pathogenesis of diabetes (#146)

6:00 PM
Corrado M Cilio

Proteomic profiling of antigenic beta cell extracts. (#148)

6:00 PM
Thomas Delong

Peptide elution to identify preproinsulin epitopes from T1D risk-associated MHC class I variants (#149)

6:00 PM
Martin Eichmann

The interplay between transplant tolerance to pancreatic islets and acute anti-viral immune responses (#150)

6:00 PM
Georgia Fousteri

Identification of CD8+ T cell targets in the major T1D autoantigen IA-2beta (#151)

6:00 PM
Yannick F Fuchs

Vaccination with tolerogenic dendritic cells impedes autoantigen-specific inflammatory response in vivo (#152)

6:00 PM
Vivienne Gibson

Thymic B cells; new players in T1D progression? (#153)

6:00 PM
Allison Green

Reversing New-Onset Diabetes in NOD mice by Combining Sitagliptin with GW9508, a GPR40 and GPR120 Dual Agonist (#154)

6:00 PM
Zhiguang Guo

Analysis of immune, metabolic and clinical biomarkers implicates inflammatory and stress pathways in the pre-clinical development of type 1 diabetes (#155)

6:00 PM
Mark Harris

Aspartame lowers the fasting blood glucose, but not the diabetes incidence, in NOD mice fed a gluten-free diet  (#156)

6:00 PM
Martin Haupt-Jorgensen

Preclinical xenotransplantation of genetically altered porcine neonatal islet cell clusters that express human CD55 and CD59 and Gal KO prevent thrombosis are a step closer to cure type 1 diabetes. (#157)

6:00 PM
Wayne J Hawthorne

On the road to unraveling the mechanistic pathways of the Instant Blood Mediated Inflammatory Reaction against Porcine Neonatal Islet Cells. (#158)

6:00 PM
Wayne J Hawthorne

Imaging the dynamics of progressive autoimmune insulitis in the NOD mouse model of type 1 diabetes (#159)

6:00 PM
Dan Holmberg

Low Dose of Rapamycin/IL-2 Treatment Protect Human Islet Allograft from Rejection in a Humanized Diabetic Mouse Model (#161)

6:00 PM
Min Hu

Increased Recognition of Post-translationally Modified Epitopes in Subjects with Type 1 Diabetes (#162)

6:00 PM
Eddie A James

Immune-suppressive Properties of Human Islet-derived Progenitor Cells (#163)

6:00 PM
Mugdha Joglekar

Doubly reactive autoantibodies define INS-IGF2 as an autoantigen largely in HLA-DQ2/8 patients newly diagnosed with autoimmune (type 1) diabetes. (#164)

6:00 PM
Norio Kanatsuna

The type 1 diabetes-associated gene CLEC16A modulates thymic epithelial cell function and impacts T cell reactivity (#165)

6:00 PM
Stephan Kissler

Mapping of epitopes of autoantigen IA-2 based on computational analysis (#166)

6:00 PM
Yu Liu

Broad activation of the IL-2R gene program in human T regulatory cells is selectively supported by low-dose IL-2 (#167)

6:00 PM
Thomas R Malek

  The serine protease granzyme A controls activation of innate immunity and type 1 interferon production in non-obese diabetic mice (#168)

6:00 PM
Zia Mollah

Natural Killer Cell Function and Phenotype in NOD and NOD-Alox15null Mice (#169)

6:00 PM
Margaret A. Morris

Glucagon-Like Peptide-1 protects human islets against cytokine-mediated beta-cell dysfunction and death: a proteomic study of the pathways involved. (#170)

6:00 PM
Lut Overbergh

Molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and mouse islets of Langerhans. (#171)

6:00 PM
Lut Overbergh

Gene expression in peripheral blood of pre-diabetic NOD mice predicts onset of type 1 diabetes and identifies new clinical biomarkers (#172)

6:00 PM
Dimeng Pang

The immunosuppressive and protective ability of glucose-regulated protein 78 (GRP78) and Bax inhibitor 1 (BI-1) for improvement of alloimmunity in ß cell transplantation (#173)

6:00 PM
Yongsoo Park

Antidiabetic and antioxidant activities of saponin fraction of Eranthemum roseum in streptozotocin-induced diabetic rats (#174)

6:00 PM
Sachin Patil

The Emerging Role of Regulatory B Cells in Type 1 Diabetes (#175)

6:00 PM
Massimo Pietropaolo

Short Course Oral Therapy with Plant-Derived Autoantigens Delays Type 1 Diabetes Onset in NOD Mice. (#176)

6:00 PM
Amanda Posgai

Serum microRNA profiling in type 1 diabetes (#177)

6:00 PM
Alberto Pugliese

Treatment of Recurrent Islet Autoimmunity in a Pancreas Transplant Recipient with Alefacept (#178)

6:00 PM
Alberto Pugliese

Deficiency in type I interferon signaling prevents the early interferon-gene signature in pancreatic islets but not type 1 diabetes in non-obese diabetic mice. (#179)

6:00 PM
Hong Sheng Quah

Characterization of the healthy interaction between the human immune cells and the pancreatic islet (#180)

6:00 PM
Miljana Radenkovic

Peripheral tolerance induction in insulin-specific CD8+ T cells (#181)

6:00 PM
Peta Reeves

Effect of Gelam honey on the oxidative stress induced signaling pathways in pancreatic hamster cells (#182)

6:00 PM
Sher Zaman Safi

Nardilysin-dependent proteolysis of cell-associated VTCN1(B7-H4): A novel pathway and biomarker in the development of type 1 diabetes (#183)

6:00 PM
Alexei Savinov

The role of IFNγ-induced expression of MHC class II by endothelial cells in efficient T cell homing to pancreatic islets (#184)

6:00 PM
Nicholas A Scott

Heparan sulfate (HS) deficiency in isolated islets is due to oxidative damage and not heparanase (Hpse)-mediated degradation (#185)

6:00 PM
Charmaine Simeonovic

Heparan sulfate (HS) status of human islet beta cells is a sensitive marker of beta cell integrity (#186)

6:00 PM
Charmaine Simeonovic

Functional impairment and phenotypic shift of natural and induced regulatory T cell in early development of Type 1 Diabetes in an experimental model (#187)

6:00 PM
Kailash Singh

IL-23 receptor signalling promotes pathogenic T cell responses and type 1 diabetes in NOD mice  (#188)

6:00 PM
Andrew PR Sutherland

Lymph node fine needle aspiration biopsy, a minimally invasive monitoring technique of antigen-specific immune responses in humans (#189)

6:00 PM
Danijela Tatovic

Lack of suppressive capacity of CD4+CD25+CD127lowFOXP3+ regulatory T cells in IL-15 rich environments (#190)

6:00 PM
Anke Theil

Perforin regulates naïve T cell responses and kills beta cells in type 1 diabetes in non-obese diabetic mice (#191)

6:00 PM
Prerak Trivedi

Superoxide-Deficient Non-Obese Diabetic Macrophages Exhibit An M2 Phenotype (#192)

6:00 PM
Hubert M Tse

Circulating microRNA-375, a potential biomarker for beta-cell death in T1D? (#193)

6:00 PM
Tina Uvebrant

Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice (#194)

6:00 PM
Tom Van Belle

1,25-dihydroxyvitamin D3 and its Analogue TX527 Promote a Regulatory T Cell Phenotype in T Cells from Type 1 Diabetic Patients (#195)

6:00 PM
Tom Van Belle

Identification of unique T1D and T2D sub-groups using unsupervised clustering of longitudinal immune biomarker data (#196)

6:00 PM
Johnna D Wesley

Catenarin, an anthraquinone compound, inhibits CXCR4 and CCR5 pathways to protect against type 1 diabetes in NOD mice (#197)

6:00 PM
Wen-Chin Yang

Slow progression to type 1 diabetes (#198)

6:00 PM
Yi Ye

Diminished Adenosine A1 receptor expression in pancreatic alpha cells may contribute to the pathology of Type 1 Diabetes (#199)

6:00 PM
Linda Yip

Inflammation and hyperglycemia induce the splicing of Deaf1 in the pancreatic lymph nodes during the progression of Type 1 diabetes (#200)

6:00 PM
Linda Yip

A Novel Hydrogel Microparticle Matrix to Deliver Autoantigen and Adjuvant utilizing the NOD mouse to prevent Type 1 Diabetes. (#201)

6:00 PM
Young-Mee Yoon

Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells (#202)

6:00 PM
Yuxia Zhang

Neocrotic death of pancreatic beta cells in type 1 diabetes (#203)

6:00 PM
Yuxing Zhao

Saraca indica fraction prevents cataract development and progression in streptozotocin-induced diabetic rats (#205)

6:00 PM
Gauresh somani